Ikarian Capital, LLC Sensei Biotherapeutics, Inc. Transaction History
Ikarian Capital, LLC
- $247 Million
- Q2 2024
A detailed history of Ikarian Capital, LLC transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 650,000 shares of SNSE stock, worth $312,000. This represents 0.16% of its overall portfolio holdings.
Number of Shares
650,000Holding current value
$312,000% of portfolio
0.16%Shares
1 transactions
Others Institutions Holding SNSE
# of Institutions
26Shares Held
2.12MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA619KShares$297,0030.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny224KShares$107,4160.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY173KShares$82,9600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA163KShares$78,3060.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX77.9KShares$37,3920.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $14.7M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...